MILLENNIUM MANAGEMENT LLC - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q4 2017$163,000
-70.2%
211,190
-44.0%
0.00%
-100.0%
Q3 2017$547,000
-51.9%
376,951
-10.6%
0.00%
-50.0%
Q2 2017$1,138,000
+2270.8%
421,564
+3475.9%
0.00%
Q1 2017$48,000
-92.2%
11,789
-92.0%
0.00%
-100.0%
Q4 2016$616,000
+182.6%
146,719
+357.1%
0.00%
Q3 2016$218,000
+31.3%
32,100
+12.1%
0.00%
Q2 2016$166,000
-4.0%
28,644
+42.5%
0.00%
Q3 2015$173,00020,1000.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2017
NameSharesValueWeighting ↓
IMS Capital Management 391,149$1,056,0001.00%
ELEMENT CAPITAL MANAGEMENT LLC 136,192$368,0000.08%
WELCH & FORBES LLC 400,614$1,081,0000.03%
Indiana Trust & Investment Management CO 19,250$52,0000.03%
FLAGSHIP HARBOR ADVISORS, LLC 15,415$34,0000.01%
LMR Partners LLP 58,775$159,0000.01%
BOSTON FINANCIAL MANGEMENT LLC 49,175$133,0000.01%
HYMAN CHARLES D 30,000$81,0000.01%
Baker Brothers Advisors 400,000$1,080,0000.01%
OneDigital Investment Advisors LLC 8,911$24,0000.01%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders